Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene

Toxicology and Applied Pharmacology
Thomas J ErichsenC P Strassburg

Abstract

UDP glucuronosyltransferases (UGTs) play an important role for drug detoxification and toxicity. UGT function is genetically modulated by single nucleotide polymorphisms (SNPs) which lead to the expression of functionally altered protein, or altered expression levels. UGT1A4 activity includes anticonvulsants, antidepressants and environmental mutagens. In this study the induction of the human UGT1A4 gene and a potential influence of genetic variation in its promoter region were analyzed. SNPs at bp -219 and -163 occurred in 9% among 109 blood donors reducing UGT1A4 transcription by 40%. UGT1A4 transcription was dioxin inducible. Reporter gene experiments identified 2 xenobiotic response elements (XRE), which were functionally confirmed by mutagenesis analyses, and binding was demonstrated by electromobility shift assays. Constitutive human UGT1A4 gene expression and induction was aryl hydrocarbon receptor (AhR)-dependent, and reduced in the presence of SNPs at bp -219 and -163. AhR-mediated regulation of the human UGT1A4 gene by two XRE and a modulation by naturally occurring genetic variability by SNPs is demonstrated, which indicates gene-environment interaction with potential relevance for drug metabolism.

References

Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D HardingB Burchell
Nov 2, 1995·The New England Journal of Medicine·P J BosmaR P Oude Elferink
Oct 18, 1996·The Journal of Biological Chemistry·Y H Chen, R H Tukey
Feb 19, 1998·Archives of Biochemistry and Biophysics·P A MünzelK W Bock
Oct 28, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y AndoT Kamataki
Dec 31, 1998·Gastroenterology·C P StrassburgR H Tukey
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·R H Tukey, C P Strassburg
Oct 6, 2000·Journal of Hepatology·C P Strassburg, M P Manns
Apr 2, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ursula EhmerChristian P Strassburg
Feb 15, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Asami MoriYoshihiro Takeuchi
Apr 28, 2005·Drug Metabolism and Pharmacokinetics·Mayumi SaekiJun-ichi Sawada
Sep 13, 2005·The Journal of Biological Chemistry·Shujuan ChenRobert H Tukey
Aug 4, 2006·Breast Cancer Research : BCR·Dongxiao SunPhilip Lazarus

❮ Previous
Next ❯

Citations

Aug 13, 2013·Pharmacogenomics·Mao Mao Söderberg, Marja-Liisa Dahl
Jun 27, 2014·Life Sciences·Ana OliveiraFélix Carvalho
Nov 11, 2009·Molecular Endocrinology·Carolyn D DuSellDonald P McDonnell
Feb 25, 2010·Cancer Prevention Research·Jay O BoyleAndrew J Dannenberg
Feb 2, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Vineetha Koroth EdavanaSusan Kadlubar
Nov 13, 2008·Critical Reviews in Clinical Laboratory Sciences·Christian P StrassburgUrsula Ehmer
Feb 2, 2010·Expert Opinion on Drug Metabolism & Toxicology·Haishan Li, Hongbing Wang
Jan 15, 2010·Drug Metabolism Reviews·Peter I MackenzieDione A Gardner-Stephen
Oct 23, 2014·Drug Metabolism Reviews·Dong Gui HuPeter I Mackenzie
Oct 28, 2008·Expert Opinion on Drug Metabolism & Toxicology·Hitoshi AshidaItsuko Fukuda
Jan 3, 2009·Toxicology and Applied Pharmacology·L RichertS O Mueller
Jan 4, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ursula EhmerChristian P Strassburg
Apr 30, 2015·Drug Metabolism and Pharmacokinetics·Qiuning WangYingjie Guo
Mar 12, 2015·Drug Metabolism and Pharmacokinetics·Shingo OdaMiki Nakajima
Feb 7, 2019·Physiological Reviews·Robyn MeechPeter I Mackenzie
Nov 6, 2009·Pharmacogenetics and Genomics·Marie-Odile Benoit-BiancamanoChantal Guillemette
Jun 12, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Aleksandra K GreerAnna Radominska-Pandya
May 15, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Takeshi IzukawaTsuyoshi Yokoi
Apr 22, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ursula EhmerChristian P Strassburg
Aug 3, 2013·Pharmacological Reviews·Francisco J Quintana, David H Sherr
Sep 1, 2019·International Journal of Molecular Sciences·Deborah MinzaghiSandrine Dubrac
Oct 23, 2009·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·U A ArgikarR P Remmel
Jul 29, 2010·Critical Reviews in Toxicology·Gary GinsbergBabasaheb Sonawane
Jun 19, 2009·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Y ChenH-H Zhou
May 20, 2021·Aquatic Toxicology·Qi MengKing Ming Chan
Sep 1, 2021·Expert Opinion on Drug Metabolism & Toxicology·Espen Molden

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here